Literature DB >> 20921423

Salt and aldosterone: a concert of bad effects.

Maria Czarina Acelajado, Eduardo Pimenta, David A Calhoun.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20921423     DOI： 10.1161/HYPERTENSIONAHA.110.160960

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

1.  Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

Authors:  Eduardo Pimenta; Richard D Gordon; Ashraf H Ahmed; Diane Cowley; Rodel Leano; Thomas H Marwick; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

2.  Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension.

Authors:  Brittany Butts; David A Calhoun; Thomas S Denney; Steven G Lloyd; Himanshu Gupta; Krishna K Gaddam; Inmaculada Aban; Suzanne Oparil; Paul W Sanders; Rakesh Patel; James F Collawn; Louis J Dell'Italia
Journal:  Free Radic Biol Med       Date:  2019-01-26       Impact factor: 7.376

3.  Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone.

Authors:  Panpan Qiang; Juan Hao; Fan Yang; Yutong Han; Yi Chang; Yunqian Xian; Yunzhao Xiong; Xiaomeng Gao; Lijuan Liang; Tatsuo Shimosawa; Qingyou Xu
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

4.  Association of Estimated Sodium Intake With Adverse Cardiac Structure and Function: From the HyperGEN Study.

Authors:  Senthil Selvaraj; Luc Djoussé; Frank G Aguilar; Eva E Martinez; Vincenzo B Polsinelli; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.